Showing results (921-930 of 1,317) with videos related to
Sort By:
Pageof 132
Annals of Hepatology|February 12, 2015
Anti-hepatitis C virus seropositivity is not associated with metabolic syndrome irrespective of age, gender and fibrosisYuan-Lung Cheng, Yuan-Chen Wang, Keng-Hsin Lan, et al.Hepatology (Baltimore, Md.)|July 19, 2012
Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer systemChia-Yang Hsu, Yun-Hsuan Lee, Cheng-Yuan Hsia, et al.Journal of Clinical Medicine|February 11, 2023
Machine Learning Predictive Models for Evaluating Risk Factors Affecting Sperm Count: Predictions Based on Health Screening IndicatorsHung-Hsiang Huang, Shang-Ju Hsieh, Ming-Shu Chen, et al.Journal of the Chinese Medical Association : JCMA|December 8, 2025
Machine-learning-based decision-tree model for patients with single-large hepatocellular carcinomaYi-Chen Lin, Chun-Ting Ho, Pei-Chang Lee, et al.JCO Precision Oncology|September 30, 2024
Using a Polygenic Risk Score to Improve the Risk Prediction of Non-Small Cell Lung Cancer in TaiwanPo-Hsin Lee, I-Chieh Chen, Yi-Ming Chen, et al.Journal of the Chinese Medical Association : JCMA|July 19, 2023
Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological responseChih-Hsuan Luan, Pin-Shuo Su, Chi-Jen Chu, et al.Proceedings of the National Academy of Sciences of the United States of America|March 25, 2026
Microstrain-engineered platinum nanoclathrins for fuel cellsZhiyong Yu, Qing Yao, Chen Sun, et al.Cancer|June 22, 2010
Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic modelsChia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, et al.Scientific Reports|January 18, 2018
Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency AblationShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 20, 2018
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis BChao-Wei Hsu, Wei-Wen Su, Chuan-Mo Lee, et al.Pageof 132